Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbCellera Biologics

3.41
-0.0600-1.73%
Post-market: 3.440.0300+0.88%19:59 EDT
Volume:8.76M
Turnover:29.47M
Market Cap:1.02B
PE:-6.00
High:3.55
Open:3.50
Low:3.24
Close:3.47
Loading ...

AbCellera Biologics Navigates Progress and Challenges in Earnings Call

TIPRANKS
·
10 May

Abcellera Biologics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

AbCellera Biologics Q1 EPS $(0.14), Inline, Sales $4.24M Miss $7.53M Estimate

Benzinga
·
09 May

AbCellera Reports Q1 2025 Results: Revenue Drops to $4.2M, Net Loss Increases to $45.6M, EPS Declines to $(0.15)

Reuters
·
09 May

BRIEF-AbCellera Q1 Revenue USD 4.2 Million Vs. IBES Estimate USD 7.53 Million

Reuters
·
09 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
08 May

3 Promising Penny Stocks With Market Caps Up To $800M

Simply Wall St.
·
24 Apr

AbCellera Biologics Is Maintained at Overweight by Keybanc

Dow Jones
·
16 Apr

AbCellera price target raised to $5 from $4 at KeyBanc

TIPRANKS
·
16 Apr

KeyBanc Remains a Buy on AbCellera Biologics (ABCL)

TIPRANKS
·
16 Apr

AbCellera to Participate at Upcoming Investor Conferences in May and June

Business Wire
·
09 Apr

Press Release: AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Dow Jones
·
04 Apr

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Business Wire
·
26 Mar

AbCellera Biologics (ABCL) Gets a Buy from Truist Financial

TIPRANKS
·
03 Mar

AbCellera Biologics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
01 Mar

AbCellera Biologics’ Earnings Call: Transition Amid Challenges

TIPRANKS
·
01 Mar

Stock Track | AbCellera Stock Plummets 16.78% in Pre-Market After Wider 2024 Loss Despite Pipeline Progress

Stock Track
·
28 Feb

Stock Track | AbCellera Stock Plunges 5.8% Pre-Market on Wider 2024 Loss Despite Pipeline Progress

Stock Track
·
28 Feb

AbCellera Biologics Inc (ABCL) Q4 2024 Earnings Call Highlights: Strategic Shifts Amid ...

GuruFocus.com
·
28 Feb

AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
28 Feb